Home › Cancer (all types) › Minnesota
Cancer (all types) clinical trials in Minnesota
50 studies for Cancer (all types) are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- University Of Minnesota /ID# 277850, Minneapolis
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07024784A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- HealthPartners Cancer Research Center /ID# 277339, Saint Louis Park
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07155187A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119A Study of JNJ-1761981 in Participants With Solid Tumors
- Mayo Clinic Rochester, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07525141A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Metro Minnesota Community Oncology Research Consortium (MMCORC), Saint Louis Park
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06901531A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Minnesota Oncology - Edina Clinic /ID# 280698, Edina
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- M Health Fairview University of Minnesota Medical Center - East Bank, Minneapolis
- Mayo Clinic, Rochester
RecruitingPhase 2/3
All ages · All sexes · Updated Sep 18, 2026 · NCT03435796Connect for Cancer Prevention Study (Connect)
- HealthPartners, Minneapolis
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 70 · All sexes · Updated Sep 17, 2026 · NCT04609072Statins to Prevent Cancer Associated Blood Clots
- Mayo Clinic, Rochester
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 3 to 25 · All sexes · Updated Sep 14, 2026 · NCT06674811A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Mayo Clinic Rochester, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06634589A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Allina Health Cancer Institute - Abbott Northwestern Hospital, Minneapolis
- HealthPartners Cancer Research Center, Saint Paul
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06119581A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Mayo Clinic Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06163534Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06072612Project: Every Child for Younger Patients With Cancer
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Up to age 25 · All sexes · Updated Aug 25, 2026 · NCT02402244Abatacept in Immune Checkpoint Inhibitor Myocarditis
- Mayo Clinic, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05335928FOG-001 in Locally Advanced or Metastatic Solid Tumors
- M Health Fairview University of Minnesota Medical Center, Minneapolis
- Mayo Clinic, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- University of Minnesota Hospital, Minneapolis
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Aug 7, 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Riverwood Healthcare Center, Aitkin
- Essentia Health - Baxter Clinic, Baxter
- Sanford Joe Lueken Cancer Center, Bemidji
- and 48 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT06580314A Study of ASP1002 in Adults for Treatment of Solid Tumors
- HealthPartners Cancer Research Center, Saint Paul
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05719558Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 518, Minneapolis
RecruitingPhase 2
Ages 18 and older · Women · Updated Jul 16, 2026 · NCT06906341Capturing Food Intake in Patients Undergoing Radiation Therapy for Cancer
- University Of Minnesota, Minneapolis
Recruiting
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07682714A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Mayo Clinic - Rochester /ID# 251164, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 13, 2026 · NCT05650632A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Scri Minnesota Oncology Hematology, P.A. /ID# 275149, Minneapolis
- Mayo Clinic-Rochester /ID# 273508, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT07023289Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Allina Health, Virginia Piper Cancer Institute, Coon Rapids
- Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley
- VPCI Oncology Research, Minneapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jul 10, 2026 · NCT05181826A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Mayo Clinic, Rochester
RecruitingPhase 1
Ages 18 and older · Men · Updated Jul 9, 2026 · NCT07103018A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Minneapolis
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT06431594Childhood Cancer Survivor Study
- Children's Hospitals & Clinics of Minnesota, Minneapolis
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Jun 17, 2026 · NCT01120353A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Mayo Clinic Rochester, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695Patient Derived Preclinical Models
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 9, 2026 · NCT05324553Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
- Mayo Clinic, Rochester
Recruiting
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT07224464A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
- Mayo Clinic Rochester, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT05954312I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester
- Metro Minnesota Community Oncology Research Consortium, Hennepin County Medical Center, Saint Louis Park
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT01042379Axelopran for Advanced Cancer in Patients Receiving Opioids
- HealthPartners Frauenshuh Cancer Research Center, Saint Louis Park
- HealthPartners Cancer Center at Regions Hospital, Saint Paul
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT07354919CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Mayo Clinic, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078INTERogating Cancer for Etiology, Prevention and Therapy Navigation
- Mayo Clinic in Rochester, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 7, 2026 · NCT06008392Multi-Cancer Detection Observational Cohort Study
- Mayo Clinic in Rochester, Rochester
RecruitingObservational studyHealthy volunteers welcome
Ages 21 and older · All sexes · Updated Apr 6, 2026 · NCT06962995From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.